{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:30:32Z","timestamp":1793406632935,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI14C1277"],"award-info":[{"award-number":["HI14C1277"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI19C0001"],"award-info":[{"award-number":["HI19C0001"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jdsjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jdermsci.2022.03.003","type":"journal-article","created":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T17:00:41Z","timestamp":1647277241000},"page":"45-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Adiponectin-derived pentapeptide ameliorates psoriasiform skin inflammation by suppressing IL-17 production in \u03b3\u03b4T cells"],"prefix":"10.1016","volume":"106","author":[{"given":"Joong Heon","family":"Suh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungyoon","family":"Ohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Ju","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Gyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Jin","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Ho","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2022.03.003_bib1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1365-2230.2001.00832.x","article-title":"Psoriasis--epidemiology and clinical spectrum","volume":"26","author":"Christophers","year":"2001","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.jdermsci.2022.03.003_bib2","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis pathogenesis and treatment","volume":"20","author":"Rendon","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jdermsci.2022.03.003_bib3","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1177\/039463201002300418","article-title":"Psoriasis relapse evaluation with week-end cyclosporine a treatment: results of a randomized, double-blind, multicenter study","volume":"23","author":"Colombo","year":"2010","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.jdermsci.2022.03.003_bib4","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jaci.2017.07.004","article-title":"Psoriasis pathogenesis and the development of novel targeted immune therapies","volume":"140","author":"Hawkes","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jdermsci.2022.03.003_bib5","first-page":"864","article-title":"Association between biologic therapies for chronic plaque psoriasis and cardiovascular events","volume":"306","author":"Ryan","year":"2011","journal-title":"J. A. M. A"},{"key":"10.1016\/j.jdermsci.2022.03.003_bib6","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3390\/ijms18061321","article-title":"Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction","volume":"18","author":"Achari","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jdermsci.2022.03.003_bib7","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1038\/s41598-017-04162-1","article-title":"Adiponectin is an endogenous anti-fibrotic mediator and therapeutic target","volume":"7","author":"Marangoni","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jdermsci.2022.03.003_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cytogfr.2016.03.014","article-title":"The role of adiponectin in obesity-associated female-specific carcinogenesis","volume":"31","author":"Nagaraju","year":"2016","journal-title":"Cytokine Growth Factor. Rev."},{"key":"10.1016\/j.jdermsci.2022.03.003_bib9","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.3390\/ijms20102519","article-title":"Adiponectin, obesity, and cancer: clash of the bigwigs in health and disease","volume":"20","author":"Parida","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jdermsci.2022.03.003_bib10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12944-021-01510-z","article-title":"Adiponectin in psoriasis and its comorbidities: a review","volume":"20","author":"Ruiyang","year":"2021","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.jdermsci.2022.03.003_bib11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jdermsci.2009.02.009","article-title":"Serum high molecular weight adiponectin levels are decreased in psoriasis patients","volume":"55","author":"Shibata","year":"2009","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jdermsci.2022.03.003_bib12","first-page":"667","article-title":"Adiponectin as an anti-inflammatory factor in the pathogenesis of psoriasis: induction of elevated serum adiponectin levels following therapy","volume":"164","author":"Shibata","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2022.03.003_bib13","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1038\/ncomms8687","article-title":"Adiponectin regulates psoriasiform skin inflammation by suppressing IL-17 production from gammadelta-T cells","volume":"6","author":"Shibata","year":"2015","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.jdermsci.2022.03.003_bib14","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202013790","article-title":"Discovery of a transdermally deliverable pentapeptide for activating AdipoR1 to promote hair growth","volume":"13","author":"Ohn","year":"2021","journal-title":"Embo. Mol. Med."},{"key":"10.1016\/j.jdermsci.2022.03.003_bib15","doi-asserted-by":"crossref","first-page":"AB261","DOI":"10.1016\/j.jaci.2014.12.1795","article-title":"Higher plasma adiponectin levels in patients with atopic dermatitis","volume":"135","author":"Daoud","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jdermsci.2022.03.003_bib16","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.febslet.2012.02.024","article-title":"Crystal structure of a single-chain trimer of human adiponectin globular domain","volume":"586","author":"Min","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jdermsci.2022.03.003_bib17","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1472-6750-11-90","article-title":"Design and development of a peptide-based adiponectin receptor agonist for cancer treatment","volume":"11","author":"Otvos","year":"2011","journal-title":"Bmc. Biotechnol."},{"key":"10.1016\/j.jdermsci.2022.03.003_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110405","article-title":"Adiponectin agonist ADP355 attenuates CCL4-induced liver fibrosis in mice","volume":"9","author":"Kumar","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jdermsci.2022.03.003_bib19","doi-asserted-by":"crossref","first-page":"5807","DOI":"10.1038\/s41467-020-19668-y","article-title":"AdipoR1\/AdipoR2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via endoplasmic reticulum-mitochondria axis","volume":"11","author":"Xu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jdermsci.2022.03.003_bib20","doi-asserted-by":"crossref","first-page":"9073","DOI":"10.1074\/jbc.M207198200","article-title":"Structure-function studies of the adipocyte-secreted hormone Acrp30\/adiponectin. Implications fpr metabolic regulation and bioactivity","volume":"278","author":"Pajvani","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jdermsci.2022.03.003_bib21","doi-asserted-by":"crossref","first-page":"40352","DOI":"10.1074\/jbc.M300365200","article-title":"Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin","volume":"278","author":"Waki","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jdermsci.2022.03.003_bib22","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/nm788","article-title":"Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase","volume":"8","author":"Yamauchi","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.jdermsci.2022.03.003_bib23","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cellimm.2015.01.011","article-title":"Dermal gammadelta T cells--What have we learned?","volume":"296","author":"O'Brien","year":"2015","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.jdermsci.2022.03.003_bib24","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1172\/JCI61862","article-title":"Rorgammat+ innate lymphocytes and gammadelta T cells initiate psoriasiform plaque formation in mice","volume":"122","author":"Pantelyushin","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jdermsci.2022.03.003_bib25","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jdermsci.2018.11.009","article-title":"TRPV1 mediates inflammation and hyperplasia in imiquimod (IMQ)-induced psoriasiform dermatitis (PsD) in mice","volume":"92","author":"Zhou","year":"2018","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jdermsci.2022.03.003_bib26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jdermsci.2017.10.016","article-title":"Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-\u03baB pathways","volume":"89","author":"Xu","year":"2018","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jdermsci.2022.03.003_bib27","first-page":"667","article-title":"Adiponectin as an anti-inflammatory factor in the pathogenesis of psoriasis: induction of elevated serum adiponectin levels following therapy","volume":"164","author":"Shibatba","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2022.03.003_bib28","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.4049\/jimmunol.0803721","article-title":"IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells","volume":"183","author":"Goodman","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2022.03.003_bib29","doi-asserted-by":"crossref","first-page":"18460","DOI":"10.1073\/pnas.0809850105","article-title":"IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells","volume":"105","author":"Korn","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181122000639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181122000639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T04:52:07Z","timestamp":1760331127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181122000639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0923181122000639"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2022.03.003","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adiponectin-derived pentapeptide ameliorates psoriasiform skin inflammation by suppressing IL-17 production in \u03b3\u03b4T cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2022.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}